Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
AMG 133 (maridebart cafraglutide) is a bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR antagonist antibody to two GLP-1 analogue agonist peptides using amino acid linkers
In summary, combination treatment with metformin and liraglutide, a GLP-1 analogue, has a synergistic effect against PA-induced endothelial dysfunction
The listed molecular weight is 1024.2 Da
Research suggests this dual action creates cellular conditions that favor energy expenditure over energy storage, giving researchers a tool to study metabolic switching mechanisms
US$ 27.24
US$ 20.23
US$ 27.25
